HSDT — Helius Medical Technologies Share Price
0.000.00%
Last trade - 00:00- $28.12m
- $27.03m
- $0.52m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 26.56 | ||
| Price to Tang. Book | 26.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 54.08 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1008.19% | ||
| Return on Equity | -688.88% | ||
| Operating Margin | -2673.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.66 | 0.52 | 0.79 | 0.64 | 0.52 | 0.51 | 0.89 | -19.05% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Helius Medical Technologies, Inc. is a neurotechnology company. The Company is engaged in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS), is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy utilizes the PoNS device in conjunction with supervised therapeutic exercise. The PoNS Therapy consists of condition-specific exercises for movement control, including balance and gait training and breathing and awareness training, which are tailored to focus on the individual patient’s functional deficits.
Directors
- Blane Walter CHM (50)
- Dane Andreeff PRE (55)
- Jeffrey Mathiesen CFO (60)
- Joyce Laviscount COO (59)
- Mitchell Tyler DRC (68)
- Sherrie Perkins IND (66)
- Edward Straw IND (82)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 18th, 2018
- Public Since
- June 27th, 2014
- No. of Shareholders
- 37
- No. of Employees
- 21
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 528,065
- Address
- 642 Newtown Yardley Road, NEWTOWN, 18940
- Web
- https://heliusmedical.com/
- Phone
- +1 2159446100
- Auditors
- BAKER TILLY US LLP
Upcoming Events for HSDT
Helius Medical Technologies Inc Annual Shareholders Meeting
Q2 2025 Helius Medical Technologies Inc Earnings Release
Similar to HSDT
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Helius Medical Technologies share price?
As of Today at 21:05 UTC, shares in Helius Medical Technologies are trading at $4.59. This share price information is delayed by 15 minutes.
How has the Helius Medical Technologies share price performed this year?
Shares in Helius Medical Technologies last closed at $4.59 and the price had moved by -88.5% over the past 365 days. In terms of relative price strength the Helius Medical Technologies share price has underperformed the S&P500 Index by -89.63% over the past year.
What are the analyst and broker recommendations for Helius Medical Technologies?
The overall consensus recommendation for Helius Medical Technologies is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Helius Medical Technologies dividend yield?
Helius Medical Technologies does not currently pay a dividend.
Does Helius Medical Technologies pay a dividend?
Helius Medical Technologies does not currently pay a dividend.
When does Helius Medical Technologies next pay dividends?
Helius Medical Technologies does not currently pay a dividend.
How do I buy Helius Medical Technologies shares?
To buy shares in Helius Medical Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Helius Medical Technologies?
As of the previous close price of $4.59, shares in Helius Medical Technologies had a market capitalisation of $28.12m.
Where are Helius Medical Technologies shares listed?
Here are the trading details for Helius Medical Technologies:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: HSDT
What kind of share is Helius Medical Technologies?
Based on an overall assessment of its quality, value and momentum Helius Medical Technologies is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Helius Medical Technologies share price forecast for 2025?
The analyst consensus target price for shares in Helius Medical Technologies is $4.00. That is 12.85% below the last closing price of $4.59.
Analysts covering Helius Medical Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$9.60 for the next financial year.
Find out moreWhat is the trend in the Helius Medical Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Helius Medical Technologies. Over the past six months, its share price has underperformed the S&P500 Index by -39.25%.
As of the last closing price of $4.59, shares in Helius Medical Technologies were trading -47.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Helius Medical Technologies PE Ratio?
The Helius Medical Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.59.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Helius Medical Technologies?
Helius Medical Technologies' management team is headed by:
- Blane Walter - CHM
- Dane Andreeff - PRE
- Jeffrey Mathiesen - CFO
- Joyce Laviscount - COO
- Mitchell Tyler - DRC
- Sherrie Perkins - IND
- Edward Straw - IND